Home › NDC Lookup › RxCUI directory › RxCUI 2001262

Pitavastatin magnesium 2 MG Oral Tablet — RxCUI 2001262

RxNorm drug concept · Semantic clinical drug
RxCUI 2001262 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2001262
Official namePitavastatin magnesium 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspitavastatin 2 MG (as pitavastatin magnesium 2.053 MG) Oral Tablet
FDA products mapped4
Package NDCs mapped18
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pitavastatin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers LDL, the “bad” cholesterol, along with a healthy diet. It is used in adults with primary hyperlipidemia. Some products, such as Livalo, are also used for inherited high c...
  • Take one tablet by mouth once a day, with or without food, at about the same time each day. Your doctor may recheck your cholesterol after about 4 weeks. Follow the directions on y...
  • The most common are muscle aches, constipation, diarrhea, back pain, and pain in the arms or legs. Most are mild. Call your doctor if muscle pain or weakness is unexplained, especi...
  • Yes. Cyclosporine must not be taken with it, and gemfibrozil should be avoided. Erythromycin and rifampin require a lower dose limit. Niacin, other fibrates and colchicine can rais...
📖 Read our full Pitavastatin guide →

🕸️ Concept Web — How Pitavastatin magnesium 2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pitavastatin magnesium 2 MG Oral Tablet RxCUI 2001262

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pitavastatin 861634
    • Pitavastatin magnesium 2001252
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zypitamag 2001255
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pitavastatin Oral Tablet 861642
    • Pitavastatin magnesium Oral Tablet 2649480
    • Pitavastatin Oral Product 1163274
    • Pitavastatin Pill 1164454
    • Pitavastatin magnesium Oral Product 2663401
    • Pitavastatin magnesium Pill 2663279
    • Pitavastatin Oral Tablet [Zypitamag] 2001257
    • Pitavastatin magnesium Oral Tablet [Zypitamag] 2657421
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pitavastatin magnesium 2 MG SCDC · 2001261
  • Pitavastatin Oral Tablet SCDF · 861642
  • Pitavastatin magnesium Oral Tablet SCDFP · 2649480
  • Pitavastatin Oral Product SCDG · 1163274
  • Pitavastatin Pill SCDG · 1164454
  • Pitavastatin magnesium Oral Product SCDGP · 2663401
  • Pitavastatin magnesium Pill SCDGP · 2663279

Brand-Name Concepts

  • Pitavastatin magnesium 2 MG Oral Tablet [Zypitamag] SBD · 2001264
  • Pitavastatin magnesium 2 MG [Zypitamag] SBDC · 2001263
  • Pitavastatin Oral Tablet [Zypitamag] SBDF · 2001257
  • Pitavastatin magnesium Oral Tablet [Zypitamag] SBDFP · 2657421
  • Zypitamag Oral Product SBDG · 2001258
  • Zypitamag Pill SBDG · 2001259
  • Zypitamag BN · 2001255

📦 FDA Products & Package NDCs

4 products · 18 package NDCs
18 package NDCs map to RxCUI 2001262 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
25208-0201-09 90 TABLET, FILM COATED in 1 BOTTLE (25208-201-09) ZYPITAMAG Medicure International Inc 2018-03-09
25208-0201-15 500 TABLET, FILM COATED in 1 BOTTLE (25208-201-15) ZYPITAMAG Medicure International Inc 2018-03-09
25208-0202-09 90 TABLET, FILM COATED in 1 BOTTLE (25208-202-09) ZYPITAMAG Medicure International Inc 2018-03-09
25208-0202-15 500 TABLET, FILM COATED in 1 BOTTLE (25208-202-15) ZYPITAMAG Medicure International Inc 2018-03-09
70771-1117-00 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1117-0) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1117-01 100 TABLET, FILM COATED in 1 BOTTLE (70771-1117-1) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1117-03 30 TABLET, FILM COATED in 1 BOTTLE (70771-1117-3) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1117-04 10 BLISTER PACK in 1 CARTON (70771-1117-4) / 10 TABLET, FIL... ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1117-05 500 TABLET, FILM COATED in 1 BOTTLE (70771-1117-5) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1117-07 1 BLISTER PACK in 1 CARTON (70771-1117-7) / 7 TABLET, FILM... ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1117-09 90 TABLET, FILM COATED in 1 BOTTLE (70771-1117-9) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-00 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1118-0) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-01 100 TABLET, FILM COATED in 1 BOTTLE (70771-1118-1) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-03 30 TABLET, FILM COATED in 1 BOTTLE (70771-1118-3) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-04 10 BLISTER PACK in 1 CARTON (70771-1118-4) / 10 TABLET, FIL... ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-05 500 TABLET, FILM COATED in 1 BOTTLE (70771-1118-5) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-07 1 BLISTER PACK in 1 CARTON (70771-1118-7) / 7 TABLET, FILM... ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
70771-1118-09 90 TABLET, FILM COATED in 1 BOTTLE (70771-1118-9) ZYPITAMAG Zydus Lifesciences Limited 2018-03-09
Observed labelers: Zydus Lifesciences Limited (14) · Medicure International Inc (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.